Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadolol for Proliferating Infantile Hemangiomas
NCT01010308Phase 2Completed
- Sponsor
- SickKids
- Start
- Nov 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nadolol in infantile hemangioma (IH), sponsored by SickKids. Started Nov 2009; status: completed.
02
Drugs
nadolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT01010308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010308.